Global Vitamins and Derivatives Market is projected to exhibit a CAGR of 3.5% During Forecast 2017-2026

Fact.MR Fact.MR

Dublin 2, Ireland, 2018-Jun-22 — /EPR Network/ — With a prime focus on vitamins and derivatives industry, research analysts of Fact. MR has publicized a comprehensive study to its online repository. This in-depth study is headlined as “Vitamins and Derivatives Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” which discusses the historic and current scenario of the global market, along with the future prospects it holds for a 10 year assessment period, 2017-2026. For the benefit of the investors of the report, this research focuses on the drivers and restraints anticipated to impact the demand for vitamins and derivatives in the coming years. Along with these insights, the report provides the readers crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=380

Key Insights from the Report Include:

1. Based on target group, the adult women segment is expected to hold its dominant position over 2026. The segment currently represents for more than 51% revenue share of the global market and expected to exhibit a CAGR of 2.8% during the assessment period

2. Consumption of vitamins and derivatives is relatively higher among adult women. This is primarily owing to a greater need for nutrition in adult women. Moreover, women all over the world are becoming increasingly conscious about their health and wellbeing.

3. Among regions, North America is expected to dominate the global vitamins and derivatives market in 2018, and the trend is likely to continue throughout the forecast period.

4. On the basis of product type, the Vitamin B segment is expected to remain highly attractive in 2018 and beyond. Currently, the segment is command for over one-fourth revenue share of the global market and expected to reach a market valuation in excess of US$ 7,300 Mn by the 2026. Over the course the forecast period, the segment is anticipated to grow by US$ 297.7 Mn annually.

5. On the basis of end use industry, the food and beverage segment is likely to retain its top position over 2026. By the end of 2026, this segment is estimated to surpass a market valuation of US$ 6,900 Mn, reflecting an above-average CAGR.

Browse Full Report with TOC- https://www.factmr.com/report/380/vitamins-derivatives-market

North America to Remain the Most Attractive Market for Vitamins and Derivatives

The market in North America is expected to remain highly lucrative for vitamins and derivatives throughout the assessment period. The region’s market is projected to exhibit a steady CAGR between 2017 and 2026. Use of vitamins and derivative supplement is significantly high in the region. Americans are increasingly inclining towards such products to ensure a balanced diet.

Vitamin B a Leading Product Type

Use of vitamin B is significantly high across the globe. Vitamin B finds application in manufacturing of various function food, cosmetics, and dietary supplements. The global sales of vitamin B currently represents for more than one-fourth share of the market in terms of revenue. Towards the end of 2026, nearly US$ 7,355.2 Mn worth vitamin B is expected to be sold worldwide.

Food & Beverage Will Remain the Largest End-Use Industry

Use of vitamins and derivatives is significantly high in the food and beverage industry. This is primarily owing to increasing consumer preference for food and beverage product that have high nutritional content and are healthy. By 2026-end, more than US$ 6,900 Mn worth vitamins and derivatives are expected to be used in the food and beverage industry.

Competition Tracking

Some of the leading players operating in the global vitamins and derivatives include Amway, Herbalife, Glanbia PLC, ADM, DSM, Abott Laboratories, GlaxoSmithKline, Glanbia, Bayer, Pfizer, Jubilant Life Sciences Limited, Lonza Group Ltd, Atrium Innovations, Inc., Sanofi, Schiff Nutrition International, Inc, BoehringerIngelheim Consumer Health Care, Fermenta Biotech Ltd., CSPC Pharmaceutical Group Limited, Bactolac Pharmaceutical, Inc., and Adisseo France S.A.S.

Buy this Report- https://www.factmr.com/checkout/380/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Food & Beverages market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us on LinkedIn: https://www.linkedin.com/company/factmr/

Matched content

Editor’s pick

Express Press Release Distribution